Today's journal articles

Immunomodulatory effects of radiofrequency ablation in a breast cancer model.

Do you need further information on any of the agents being evaluated in the trial(s) below?  Let us know...

New Clinical Trials

A Trial of Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type Non-Small-Cell Lung Cancer

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

Previous Journal Entries

Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.

Differential protein biomarker expression and their time-course in patients with a spectrum of stable and unstable coronary syndromes in the Integrated Biomarker and Imaging Study-1 (IBIS-1).

Synthesis, in vitro and in vivo studies of Gd - DTPA - XDA - D1 - Glc(OH) complex as a new potential MRI contrast agent.

Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen.

Biomarkers for predicting the sensitivity of cancer cells to TRAIL-R1 agonistic monoclonal antibody.

Design, synthesis and in vitro characterization of Glucagon - Like Peptide - 1 derivatives for pancreatic beta cell imaging by SPECT.

Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.

In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents.

Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis.

Site - specific labeling of 'second generation' annexin V with (99m)Tc(CO)(3) for improved imaging of apoptosis in vivo.

[Lys(DOTA)(4)]BVD15, a novel and potent neuropeptide Y analog designed for Y(1) receptor - targeted breast tumor imaging.

Pancreatic cancer therapy with a novel pump for controlled drug release.

An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer.

Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.

The value of C-reactive protein in screening for future coronary heart disease events.

CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis.

Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics.

Evaluation of the Medtronic Exponent Self-Expanding Carotid Stent System With the Medtronic Guardwire Temporary Occlusion and Aspiration System in the Treatment of Carotid Stenosis. Combined From the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II Trials.

Diagnostic potential in prostate cancer of a panel of urinary molecular tumor markers.

Today's News Items

St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors

Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval

Training Courses & Meetings

No events listed

Previous News Items

St. Jude Medical Announces IRASE AF Clinical Trial to Evaluate Cardiac Ablation Catheter System for Treatment of Atrial Fibrillation

Veran Medical Receives FDA Clearances to Expand Uses for ig4 Navigation System to Use Ultrasound and 3D Fluoroscopic X-ray

---

For faster discovery, automatically organize PubMed results into categories